Is Parnax Lab overvalued or undervalued?

As of 17 October 2025, Parnax Lab's valuation grade has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued based on its financial metrics, with a PE ratio of 13.55, an EV to EBITDA of 8.33, and a ROE of 13.86%. In comparison to its peers, Parnax Lab's valuation metrics are relatively moderate, especially when compared to Elitecon International, which is deemed very expensive with a PE ratio of 358.65, and PTC India, which is very attractive with a PE ratio of 7.81.
Despite the recent decline in stock performance, with a year-to-date return of -24.08% compared to the Sensex's 7.44%, Parnax Lab's financial ratios suggest it is neither undervalued nor overvalued but rather fairly positioned in the market. The company's EV to Sales ratio of 1.12 further supports this assessment, indicating that while it may not be a bargain, it is also not excessively priced relative to its earnings potential.